Cresset announces release of forgeV10.1
Cresset, innovative provider of chemistry software and services, announces the release of a new version of its computational chemistry workbench forgeV10.
Chemistry software available free to degree students and at low cost to academic researchers
Cresset, innovative provider of chemistry software and services, expands their Academic Access program, offering free software bursaries for all PhD and postdoc students and low cost licenses for all other academic researchers.
Next generation XED force field enables accurate modelling of ligand-protein interactions
Cresset announces new release of the popular XedTools package, including the next generation of the popular XED force field which contains command line utilities for studying molecular interactions using the XED molecular mechanics force field.
Is chocolate druggable? The latest news from Cresset
The pharmacology of chocolate is the subject of just one of the articles featured by Cresset in its latest newsletter.
Cresset announces excellent 2012 sales figures and growth
Cresset, innovative provider of computational chemistry software and consulting services, announces excellent 2012 sales figures and growth.
Cresset publishes its January 2013 Newsletter
Cresset BioMolecular Discovery's latest newsletter includes: Field Based Chemistry North America and Europe; Virtual Screening Webinar; Using Pharmacophores to Find New Targets for Existing Drugs; Great Science Makes a Great Consulting Project; What Good Was Christmas π Without a Cuppa!
Biologically intelligent database searching for lead identification and patent fortification
Cresset, innovative provider of chemistry software and services, announces the completion of its Cresset proV10 suite with the relaunch of its highly successful FieldScreen system as blazeV10 for ligand based virtual screening.
sparkV10 chosen to facilitate hit optimisation process in ProMining Therapeutics
ProMining Therapeutics Ltd has chosen to license Cresset's sparkV10 software for assistance in its hit-to-lead optimization efforts.
Cresset December 2012 Newsletter
2012 has been a time of consolidation and growth for Cresset. The company says: We sincerely hope that as we seek ever better understandings of molecular interactions, Cresset will continue to make a real difference to your research.
torchV10 chosen to add value to enzyme engineering
Es-is Technologies Ltd has chosen to license torchV10 for use in enzyme engineering.
The trend to outsource computational chemistry
Computational chemistry is a highly skilled scientific field. It has delivered proven results, particularly in the areas of lead identification and optimization. However, maintaining an in-house team is a luxury often confined to the major pharmaceutical giants.
Cresset November 2012 Newsletter
Cresset can help you generate innovative chemical starting points for your targets; optimize your lead series’ activity, ADME and toxicity; identify the binding mode of a target with/without a structure; understand the SAR of your compounds; hop between bioisosteric chemical scaffolds; and much more.
torchV10lite: Free software transforms the way you see and draw molecules
Cresset, innovative provider of software and services, releases torchV10lite - a free 3D molecular viewer, sketcher and editor.
torchV10 brings the next generation of molecule design to the desktop
Cresset, innovative provider of software and services, announces the release of torchV10, a complete desktop molecular design and 3D SAR tool for medicinal chemists.
Cresset unveils sparkV10 – the update to FieldStere, a leading bioisostere software tool
Cresset, innovative provider of software and services for molecule designers, unveils sparkV10, the next generation of its bioisostere software tool FieldStere. Building on FieldStere’s industry-leading ability to find structurally novel biologically equivalent replacements for key moieties in molecules, this update provides powerful new capabilities including Cresset’s new XED3 force field, new…
Cresset announces appointment of David Bardsley as Sales Director
Cresset BioMolecular Discovery is delighted to announce the appointment of Dr David Bardsley to the newly created role of Sales Director at Cresset Group. David joins Cresset from Synergy Health Plc where, as Sales Director of the Healthcare Solutions division, he was responsible for the organization delivering product solutions to healthcare professionals and institutions.
Isogenica, Cresset Group and Biolauncher secure funding from UK’s Technology Strategy Board
Cresset, Welwyn Garden City UK, innovative provider of software and services together with Isogenica and Biolauncher, Cambridge UK, announce funding from the Technology Strategy Board, the UK’s innovation agency, for a £1M project to develop a highly-scalable approach to small molecule drug discovery.
Cresset launches forgeV10 and range of next generation chemistry software
Cresset, innovative provider of software and services for molecule designers launches forgeV10 a powerful computational suite to understand SAR and design. forgeV10 gives computational chemists control and insight into activity data enabling the planning and direction of projects with confidence. ForgeV10 uses the shape and electrostatic character of molecules to create qualitative and…